share_log

T2 Biosystems | 8-K: T2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel

T2 Biosystems | 8-K:T2 Biosystems公布2023年第三季度初步财务业绩和宣布向FDA提交510(k)申请以扩大T2Bacteria Panel的病原体检测

美股SEC公告 ·  2023/10/12 13:32
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息